SCHEMBL2201457

SCHEMBL2201457

Brc1ccc2c3c(ccc(-c4ccccc4)c13)-c1c-2c(-c2ccccc2)c2ccccc2c1-c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 3/20 0.41
ALDH1A1 P00352 3/20 0.41
KDM4E B2RXH2 2/20 0.39
MAPT P10636 2/20 0.39
TDP1 Q9NUW8 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
ESR1 P03372 1/20 0.35
ESR2 Q92731 1/20 0.35
PARP1 P09874 1/20 0.34
CYP1B1 Q16678 4/20 0.33
CYP1A2 P05177 2/20 0.33
ENPP1 P22413 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
GPR84 Q9NQS5 1/20 0.33
EGFR P00533 1/20 0.33
ACHE P22303 1/20 0.32
PLK4 O00444 1/20 0.31
AURKA O14965 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13318342 0.95 MAPK1 (0.40) MAPK1ALDH1A1KDM4EMAPTTDP1
SCHEMBL3682900 0.93 MAPK1 (0.41) MAPK1ALDH1A1KDM4EMAPTTDP1
SCHEMBL2865816 0.89 PARP1 (0.41) MAPK1ALDH1A1KDM4EMAPTTDP1
SCHEMBL13318335 0.88 MAPK1 (0.41) MAPK1ALDH1A1KDM4EMAPTTDP1
SCHEMBL2200391 0.85 MAPT (0.36) MAPK1ALDH1A1KDM4EMAPTTDP1
SCHEMBL30170061 0.82 CYP1A2 (0.51) MAPK1ALDH1A1KDM4EMAPTTDP1
SCHEMBL959783 0.82 CYP1A2 (0.51) MAPK1ALDH1A1KDM4EMAPTTDP1
SCHEMBL12449294 0.81 CYP1A2 (0.41) MAPK1ALDH1A1KDM4EMAPTTDP1
SCHEMBL13318271 0.80 CYP1A1 (0.38) MAPK1ALDH1A1KDM4EMAPTTDP1
SCHEMBL12449293 0.79 CYP1A2 (0.45) MAPK1ALDH1A1KDM4EMAPTTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109111461-B Novel compound and application thereof in electroluminescent device 北京鼎材科技有限公司 2021-09-10 CN disclosed
US-7977869-B2 Organic luminescent device and benzo[k]fluoranthene compound CANON KABUSHIKI KAISHA (JP) 2011-07-12 US disclosed
US-20090278447-A1 ORGANIC LUMINESCENT DEVICE AND BENZO[k]FLUORANTHENE COMPOUND CANON KABUSHIKI KAISHA (JP) 2009-11-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090278447-A1 ORGANIC LUMINESCENT DEVICE AND BENZO[k]FLUORANTHENE COMPOUND FOXK1, KCNK10, F10 MAPK1 1803/4885ALDH1A1 1170/4885KDM4E 1950/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.